Massachusetts Wealth Management Purchases 147 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Massachusetts Wealth Management lifted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.1% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 13,368 shares of the company’s stock after acquiring an additional 147 shares during the quarter. Massachusetts Wealth Management’s holdings in GE HealthCare Technologies were worth $1,255,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Wellington Management Group LLP boosted its stake in GE HealthCare Technologies by 575.6% in the 4th quarter. Wellington Management Group LLP now owns 21,118 shares of the company’s stock worth $1,633,000 after purchasing an additional 17,992 shares during the period. Park Avenue Securities LLC bought a new position in GE HealthCare Technologies in the 1st quarter worth about $227,000. Wealthcare Advisory Partners LLC bought a new position in GE HealthCare Technologies in the 1st quarter worth about $255,000. Wealth Enhancement Advisory Services LLC boosted its stake in GE HealthCare Technologies by 0.9% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 197,493 shares of the company’s stock worth $17,954,000 after purchasing an additional 1,817 shares during the period. Finally, Artemis Investment Management LLP boosted its stake in GE HealthCare Technologies by 23.6% in the 1st quarter. Artemis Investment Management LLP now owns 112,004 shares of the company’s stock worth $10,177,000 after purchasing an additional 21,401 shares during the period. Institutional investors own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

GEHC has been the subject of several analyst reports. JPMorgan Chase & Co. initiated coverage on GE HealthCare Technologies in a research note on Monday, September 9th. They issued a “neutral” rating and a $90.00 target price for the company. UBS Group downgraded GE HealthCare Technologies from a “neutral” rating to a “sell” rating and dropped their price target for the company from $84.00 to $74.00 in a research report on Thursday, September 26th. Redburn Atlantic upgraded GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a research report on Wednesday, September 18th. Finally, Stifel Nicolaus lifted their price target on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research report on Monday, September 30th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $94.23.

Insider Transactions at GE HealthCare Technologies

In other news, CEO Thomas J. Westrick sold 2,750 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total value of $222,145.00. Following the sale, the chief executive officer now directly owns 17,509 shares in the company, valued at approximately $1,414,377.02. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Trading Up 0.5 %

GE HealthCare Technologies stock traded up $0.43 during trading hours on Friday, reaching $89.33. The company had a trading volume of 327,667 shares, compared to its average volume of 2,983,448. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.06 and a quick ratio of 0.82. The company has a 50-day moving average price of $88.35 and a 200 day moving average price of $83.45. The firm has a market cap of $40.78 billion, a price-to-earnings ratio of 25.99, a P/E/G ratio of 3.39 and a beta of 1.18. GE HealthCare Technologies Inc. has a 12-month low of $62.35 and a 12-month high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, topping analysts’ consensus estimates of $0.98 by $0.02. The business had revenue of $4.84 billion for the quarter, compared to analysts’ expectations of $4.88 billion. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The business’s quarterly revenue was up .5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.92 EPS. Equities analysts forecast that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a $0.03 dividend. The ex-dividend date is Friday, October 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.13%. GE HealthCare Technologies’s dividend payout ratio is currently 3.51%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.